Elevated C reactive protein in adults predicts the later development of late-onset or very-late-onset schizophrenia

Evidence-Based Mental Health

Volumn 18, Issue 2, 2015, Pages e2-

  Dickerson, Faith ^a  

^a SHEPPARD PRATT HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

BLOOD; FEMALE; HUMAN; MALE; PSYCHOTIC DISORDERS; REGISTER; SCHIZOPHRENIA;

C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; PSYCHOTIC DISORDERS; REGISTRIES; SCHIZOPHRENIA;

EID: 84928404570     PISSN: 13620347     EISSN: None     Source Type: Journal    
DOI: 10.1136/eb-2014-101996     Document Type: Note

References (6)

1. Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 2011;70:663–71.
2. Dickerson F, Stallings C, Origoni A, et al. C-reactive protein is elevated in schizophrenia. Schizophr Res 2013;143:198–202.
3. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54.
4. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805–12.
5. Wium-Andersen MK, Ørsted DD, Nielsen SF, et al. Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals. JAMA Psychiatry 2013;70:176–84.
6. Benros ME, Mortensen PB, Eaton WW. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci 2012;1262:56–66.